Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
Journal of Alzheimer'S Disease : JAD|September 17, 2016
EEG Dominant Frequency Peak Differentiates Between Alzheimer's Disease and Frontotemporal Lobar DegenerationJoery Goossens, Jorne Laton, Jeroen Van Schependom, et al.
Alzheimer'S Research & Therapy|July 16, 2017
No added diagnostic value of non-phosphorylated tau fraction (p-tau<sub>rel</sub>) in CSF as a biomarker for differential dementia diagnosisJoery Goossens, Maria Bjerke, Hanne Struyfs, et al.
Frontiers in Neurology|July 21, 2017
Multicenter Analytical Validation of Aβ40 ImmunoassaysLinda J C van Waalwijk van Doorn, Luka Kulic, Marleen J A Koel-Simmelink, et al.
Journal of Alzheimer'S Disease : JAD|September 5, 2017
The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical SettingEllis Niemantsverdriet, Julie Ottoy, Charisse Somers, et al.
Journal of Alzheimer'S Disease : JAD|May 22, 2018
A Retrospective Belgian Multi-Center MRI Biomarker Study in Alzheimer's Disease (REMEMBER)Ellis Niemantsverdriet, Annemie Ribbens, Christine Bastin, et al.
EMBO Molecular Medicine|March 5, 2016
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markersMarc Suárez-Calvet, Gernot Kleinberger, Miguel Ángel Araque Caballero, et al.
Alzheimer'S Research & Therapy|June 14, 2024
Brain age as a biomarker for pathological versus healthy ageing - a REMEMBER studyMandy M J Wittens, Stijn Denissen, Diana M Sima, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairmentSanna-Kaisa Herukka, Anja Hviid Simonsen, Niels Andreasen, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 26, 2017
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementiaAnja Hviid Simonsen, Sanna-Kaisa Herukka, Niels Andreasen, et al.
Alzheimer'S Research & Therapy|June 16, 2025
Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical dataMandy M J Wittens, Diana M Sima, Arne Brys, et al.
Pageof 4